Skip to main content

Sign In

Sign In

Portal Training Materials

Provider Newsletter

Join Our Network

New CPT Codes

06/25/2020
CPT CodesDescription
J0129Injection, abatacept, 10 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)
J0178Injection, aflibercept, 1 mg
J0179Injection, brolucizumab-dbll, 1 mg
J0180Injection, agalsidase beta, 1 mg
J0185Injection, aprepitant, 1 mg
J0202Injection, alemtuzumab, 1 mg
J0221Injection, alglucosidase alfa, (Lumizyme), 10 mg
J0222Injection, patisiran, 0.1 mg 
J0256Injection, alpha 1-proteinase inhibitor (human), not otherwise specified, 10 mg
J0257Injection, alpha 1 proteinase inhibitor (human), (GLASSIA), 10 mg
J0364Injection, apomorphine hcl, 1 mg
J0485Injection, belatacept, 1 mg
J0490Injection, belimumab, 10 mg
J0517Injection, benralizumab, 1 mg
J0565Injection, bezlotoxumab, 10 mg
J0567Injection, cerliponase alfa, 1 mg
J0570Buprenorphine implant, 74.2 mg
J0584Injection, burosumab-twza 1 mg
J0585Injection, onabotulinumtoxinA, 1 unit
J0586Injection, abobotulinumtoxinA, 5 units
J0587Injection, rimabotulinumtoxinB, 100 units
J0588Injection, incobotulinumtoxinA, 1 unit
J0593Injection, lanadelumab-flyo, 1 mg (code may be used for Medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
J0596Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units
J0597Injection, C-1 esterase inhibitor (human), Berinert, 10 units
J0598Injection, C-1 esterase inhibitor (human), Cinryze, 10 units
J0599Injection, c-1 esterase inhibitor (human), (haegarda), 10 units
J0606Injection, etelcalcetide, 0.1 mg
J0638Injection, canakinumab, 1 mg
J0641Injection, levoleucovorin, 0.5 mg
J0642Injection, levoleucovorin (Khapzory), 0.5 mg
J0717Injection, certolizumab pegol, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J0775Injection, collagenase, clostridium histolyticum, 0.01 mg
J0800Injection, corticotropin, up to 40 units
J0850Injection, cytomegalovirus immune globulin intravenous (human), per vial
J0881Injection, darbepoetin alfa, 1 mcg (non-ESRD use)
J0885Injection, epoetin alfa, (for non-ESRD use), 1000 units
J0894Injection, decitabine, 1 mg
J0897Injection, denosumab, 1 mg
J1095Injection, dexamethasone 9%, intraocular, 1 mcg
J1096Dexamethasone, lacrimal ophthalmic insert, 0.1 mg 
J1290Injection, ecallantide, 1 mg
J1300Injection, eculizumab, 10 mg
J1301Injection, edaravone, 1 mg
J1303Injection, ravulizumab-cwvz, 10 mg
J1322Injection, elosulfase alfa, 1 mg
J1325Injection, epoprostenol, 0.5 mg
J1428Injection, eteplirsen, 10 mg
J1442Injection, filgrastim (G-CSF), excludes biosimilars, 1 microgram
J1447Injection, tbo-filgrastim, 1 mcg
J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
J1458Injection, galsulfase, 1 mg
J1459Injection, immune globulin (Privigen), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1555Injection, immune globulin (cuvitru), 100 mg
J1556Injection, immune globulin (Bivigam), 500 mg
J1557Injection, immune globulin, (Gammaplex), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1559Injection, immune globulin (Hizentra), 100 mg
J1561Injection, immune globulin, (Gamunex/Gamunex-C/Gammaked), nonlyophilized (e.g., liquid), 500 mg
J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
J1568Injection, immune globulin, (Octagam), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1569Injection, immune globulin, (Gammagard liquid), nonlyophilized, (e.g., liquid), 500 mg
J1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
J1572Injection, immune globulin, (Flebogamma/Flebogamma Dif), intravenous, nonlyophilized (e.g., liquid), 500 mg
J1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
J1575Injection, immune globulin/hyaluronidase, 100 mg immuneglobulin
J1599Injection, immune globulin, intravenous, non-lyophilized (e.g. liquid), not otherwise specified, 500 mg
J1602Injection, golimumab, 1 mg, for intravenous use
J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
J1740Injection, ibandronate sodium, 1 mg
J1743Injection, idursulfase, 1 mg
J1744Injection, icatibant, 1mg
J1745Injection, infliximab, excludes biosimilar, 10 mg
J1746Injection, ibalizumab-uiyk, 10 mg
J1786Injection, imiglucerase, 10 units
J1833Injection, isavuconazonium, 1 mg
J1930Injection, lanreotide, 1 mg
J1931Injection, laronidase, 0.1 mg
J2062Loxapine for inhalation, 1 mg
J2182Injection, mepolizumab, 1 mg
J2323Injection, natalizumab, 1 mg
J2326Injection, nusinersen, 0.1 mg
J2350Injection, ocrelizumab, 1 mg
J2353Injection, octreotide, depot form for intramuscular injection, 1 mg
J2357Injection, omalizumab, 5 mg
J2469Injection, palonosetron HCl, 25 mcg
J2502Injection, pasireotide long acting, 1 mg
J2503Injection, pegaptanib sodium, 0.3 mg
J2505Injection, pegfilgrastim, 6 mg
J2507Injection, Pegloticase, 1 mg
J2562Injection, plerixafor, 1 mg
J2724Injection, protein C concentrate, intravenous, human, 10 IU
J2778Injection, ranibizumab, 0.1 mg
J2786Injection, reslizumab, 1 mg
J2793Injection, rilonacept, 1 mg
J2796Injection, romiplostim, 10 mcg
J2797Injection, rolapitant, 0.5 mg
J2820Injection, sargramostim (GM-CSF), 50 mcg
J2840Injection, sebelipase alfa, 1 mg
J2860Injection, siltuximab, 10 mg
J3060Injection, taliglucerase alfa, 10 units
J3111Injection, romosozumab-aqqg, 1 mg
J3145Injection, testosterone undecanoate, 1 mg
J3240Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
J3245Injection, tildrakizumab, 1 mg
J3262Injection, tocilizumab, 1 mg
J3285Injection, treprostinil, 1 mg
J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
J3316Injection, triptorelin, extended-release, 3.75 mg
J3358Ustekinumab, for intravenous injection, 1 mg
J3380Injection, vedolizumab, 1 mg
J3385Injection, velaglucerase alfa, 100 units
J3397Injection, vestronidase alfa-vjbk, 1 mg
J3398Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
J3489Injection, zoledronic acid, 1 mg
J3490Unclassified drugs
J3590Unclassified biologics
J7170Injection, emicizumab-kxwh, 0.5 mg
J7175Injection, factor x, (human), 1 i.u. (New Code: 01/01/2017)
J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
J7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco (New Code: 01/01/2017)
J7180Injection, factor XIII (antihemophilic factor, human), 1 IU
J7181Injection, factor XIII A-subunit, (recombinant), per IU
J7182Injection, factor VIII, (antihemophilic factor, recombinant), (NovoEight), per IU
J7183Injection, von Willebrand factor complex (human), Wilate, 1 IU vWF:RCo
J7185Injection, factor VIII (antihemophilic factor, recombinant) (XYNTHA), per IU
J7186Injection, antihemophilic factor VIII/von Willebrand factor complex (human), per factor VIII i.u.
J7187Injection, von Willebrand factor complex (Humate-P), per IU VWF:RCO
J7188Injection, factor VIII (antihemophilic factor, recombinant), per IU
J7189Factor VIIa (antihemophilic factor, recombinant), per 1 mcg
J7190Factor VIII (antihemophilic factor, human) per IU
J7192Factor VIII (antihemophilic factor, recombinant) per IU, not otherwise specified
J7193Factor IX (antihemophilic factor, purified, nonrecombinant) per IU
J7194Factor IX complex, per IU
J7195Injection, factor IX (antihemophilic factor, recombinant) per IU, not otherwise specified
J7198Antiinhibitor, per IU
J7199Hemophilia clotting factor, not otherwise classified
J7200Injection, factor IX, (antihemophilic factor, recombinant), Rixubis, per IU
J7201Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. (Revised Code: 01/01/2017)
J7202Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. (New Code: 01/01/2017)
J7203Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu
J7205Injection, factor VIII Fc fusion protein (recombinant), per IU
J7207Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. (New Code: 01/01/2017)
J7208Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u.
J7209Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. (New Code: 01/01/2017)
J7210Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u.
J7211Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u.
J7311Fluocinolone acetonide, intravitreal implant
J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
J7313Injection, fluocinolone acetonide, intravitreal implant, 0.01 mg
J7314Injection, fluocinolone acetonide, intravitreal implant (Yutiq), 0.01 mg
J7316Injection, ocriplasmin, 0.125 mg
J7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
J7320Hyaluronan or derivative, GenVisc 850, for intra-articular injection, 1 mg
J7321Hyaluronan or derivative, Hyalgan or Supartz, for intra-articular injection, per dose
J7322Hyaluronan or derivative, Hymovis, for intra-articular injection, 1 mg
J7323Hyaluronan or derivative, Euflexxa, for intra-articular injection, per dose
J7324Hyaluronan or derivative, Orthovisc, for intra-articular injection, per dose
J7325Hyaluronan or derivative, Synvisc or Synvisc-One, for intra-articular injection, 1 mg
J7326Hyaluronan or derivative, Gel-One, for intra-articular injection, per dose
J7327Hyaluronan or derivative, Monovisc, for intra-articular injection, per dose
J7328Hyaluronan or derivative, Gel-Syn, for intra-articular injection, 0.1 mg
J7329Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg
J7331Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg
J7332Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg
J7336Capsaicin 8% patch, per square centimeter
J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
J9015Injection, aldesleukin, per single use vial
J9022Injection, atezolizumab, 10 mg
J9023Injection, avelumab, 10 mg
J9025Injection, azacitidine, 1 mg
J9027Injection, clofarabine, 1 mg
J9033Injection, bendamustine hcl (treanda), 1 mg
J9034Injection, bendamustine hcl (bendeka), 1 mg
J9035Injection, bevacizumab, 10 mg " to "Injection, bevacizumab, (Avastin) 10 mg (Cancer indications only; ophthalmologic injections do not require PA. Submit under J3490 with NDC
J9036Injection, bendamustine hydrochloride, (Belrapzo), 1 mg
J9039Injection, blinatumomab, 1 microgram
J9041Injection, bortezomib (Velcade), 0.1 mg
J9042Injection, brentuximab vedotin, 1 mg
J9043Injection, cabazitaxel, 1 mg
J9044Injection, bortezomib, not otherwise specified, 0.1 mg
J9047Injection, Carfilzomib, 1 mg
J9055Injection, cetuximab, 10 mg
J9057Injection, copanlisib, 1 mg
J9118Injection, calaspargase pegol-mknl, 10 units
J9119Injection, cemiplimab-rwlc, 1 mg 
J9145Injection, daratumumab, 10 mg
J9153Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
J9173Injection, durvalumab, 10 mg
J9176Injection, elotuzumab, 1 mg
J9179Injection, eribulin mesylate, 0.1 mg
J9199Injection, gemcitabine HCl (Infugem), 200 mg
J9203Injection, gemtuzumab ozogamicin, 0.1 mg
J9204Injection, mogamulizumab-kpkc, 1 mg 
J9205Injection, irinotecan liposome, 1 mg
J9207Injection, ixabepilone, 1 mg
J9210Injection, emapalumab-lzsg, 1 mg  
J9219Leuprolide acetate implant, 65 mg
J9225Histrelin implant (Vantas), 50 mg
J9226Histrelin implant (supprelin la), 50 mg
J9228Injection, ipilimumab, 1 mg
J9229Injection, inotuzumab ozogamicin, 0.1 mg
J9262Injection, omacetaxine mepesuccinate, 0.01 mg
J9263Injection, oxaliplatin, 0.5 mg
J9264Injection, paclitaxel protein-bound particles, 1 mg
J9269Injection, tagraxofusp-erzs, 10 micrograms
J9271Injection, pembrolizumab, 1 mg
J9285Injection, olaratumab, 10 mg
J9295Injection, necitumumab, 1 mg
J9299Injection, nivolumab, 1 mg
J9301Injection, obinutuzumab, 10 mg
J9302Injection, ofatumumab, 10 mg
J9303Injection, panitumumab, 10 mg
J9305Injection, pemetrexed, 10 mg
J9306Injection, pertuzumab, 1 mg
J9307Injection, pralatrexate, 1 mg
J9308Injection, ramucirumab, 5 mg
J9309Injection, polatuzumab vedotin-piiq, 1 mg
J9311Injection, rituximab 10 mg and hyaluronidase
J9312Injection, rituximab, 10 mg
J9313Injection, moxetumomab pasudotox-tdfk, 0.01 mg
J9315Injection, romidepsin, 1 mg
J9325Injection, talimogene laherparepvec, per 1 million plaque forming units
J9328Injection, temozolomide, 1 mg
J9330Injection, temsirolimus, 1 mg
J9340Injection, thiotepa, 15 mg
J9352Injection, trabectedin, 0.1 mg
J9354Injection, ado-trastuzumab emtansine, 1 mg
J9355Injection, trastuzumab, excludes biosimilar, 10 mg
J9356Injection, trastuzumab, 10 mg and Hyaluronidase-oysk
J9371Injection, vincristine sulfate liposome, 1 mg; 1 mg = 1 billable unit
J9400Injection, ziv-aflibercept, 1 mg
Q2041Axicabtagene Ciloleucel, up to 200 million autologous Anti-CD19 CAR T Cells, including leukapheresis and dose preparation procedures, per infusion
Q2042Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Q2043Sipuleucel-T, minimum of 50 million autologous cd54+ cells activated with PAP-GM-CSF, including leukapheresis and all other preparatory procedures, per infusion
Q2049Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
Q2050Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
Q4074Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms
Q5101Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram
Q5103Injection, infliximab-dyyb, biosimilar, (Inflectra), 10 mg
Q5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mg
Q5106Injection, epoetin alfa, biosimilar, (Retacrit) (for non-ESRD use), 1000 units
Q5107Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg
Q5108Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg
Q5110Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
Q5111Injection, pegfilgrastim-cbqv, biosimilar, (Udenyca), 0.5 mg
Q5112Injection, trastuzumab-dttb, biosimilar, (Ontruzant), 10 mg
Q5113Injection, trastuzumab-pkrb, biosimilar, (Herzuma), 10 mg 
Q5114Injection, Trastuzumab-dkst, biosimilar, (Ogivri), 10 mg
Q5115Injection, rituximab-abbs, biosimilar, 10 mg
Q5116Injection, trastuzumab-qyyp, biosimilar, (Trazimera), 10 mg
Q5117Injection, trastuzumab-anns, biosimilar, (Kanjinti), 10 mg
Q5118Injection, bevacizumab-bvcr, biosimilar, (Zirabev), 10 mg